Literature DB >> 34498201

Long term effects of surgical and transcatheter aortic valve replacement on FFRCT in patients with severe aortic valve stenosis.

Vincent Michiels1, Daniele Andreini2,3, Edoardo Conte2, Kaoru Tanaka4, Dries Belsack4, Jan Nijs5, Ines Van Loo5, Jean Francois Argacha6, Bert Vandeloo6, Bram Roosens6, Karen Vandenbussche6, Bernard Cosyns6.   

Abstract

The long-term variations of fractional flow reserve derived from coronary computed tomography (FFRCT) after surgical (SAVR) or transcatheter (TAVR) aortic valve replacement in patients with severe aortic valve stenosis (AS) have not been investigated. A total of 25 patients with isolated, severe AS underwent coronary computed tomography with 3-vessel FFRCT analysis (Heartflow Inc.-Redwood City, California, USA) and measurement of total coronary volume (V), left ventricular mass (M) and their ratio (V/M) before and 6 months after SAVR or TAVR. A significant increase in V/M due to a decrease in left ventricular mass 6 months after intervention was observed, whereas total coronary volume did not change (coronary volume pre: 2924.5 ± 867.9 mm3, coronary volume post: 2844.2 ± 792.8 mm3, P = 0.158; LV mass pre: 151.7 ± 40.7 g, LV mass post: 127.3 ± 34.7 g, P < 0.001; V/M pre: 19.5 ± 4.1 mm3/g, V/M post: 22.7 ± 4.28 mm3/g, P = 0.002). FFRCT (expressed as area under the virtual pullback curve) remained constant. This proof-of-concept study showed that FFRCT was not subject to the confounding effect of left ventricular mass regression after SAVR or TAVR. Despite significant left ventricular remodeling at 6 months after AS treatment, FFRCT values remained constant. Further studies are needed comparing the performance of the different invasive and non-invasive coronary physiological indices in this patient cohort.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Aortic stenosis; Cardiac computed tomography; Coronary physiology

Mesh:

Year:  2021        PMID: 34498201     DOI: 10.1007/s10554-021-02401-1

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  5 in total

Review 1.  Noninvasive Fractional Flow Reserve Derived From Coronary CT Angiography: Clinical Data and Scientific Principles.

Authors:  James K Min; Charles A Taylor; Stephan Achenbach; Bon Kwon Koo; Jonathon Leipsic; Bjarne L Nørgaard; Nico J Pijls; Bernard De Bruyne
Journal:  JACC Cardiovasc Imaging       Date:  2015-10

2.  Same Lesion, Different Artery, Different FFR!?

Authors:  Nils P Johnson; Richard L Kirkeeide; K Lance Gould
Journal:  JACC Cardiovasc Imaging       Date:  2018-01-17

3.  Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE.

Authors:  Timothy A Fairbairn; Rebecca Dobson; Lyne Hurwitz-Koweek; Hitoshi Matsuo; Bjarne L Norgaard; Niels Peter Rønnow Sand; Koen Nieman; Jeroen J Bax; Gianluca Pontone; Gilbert Raff; Kavitha M Chinnaiyan; Mark Rabbat; Tetsuya Amano; Tomohiro Kawasaki; Takashi Akasaka; Hironori Kitabata; Sukumaran Binukrishnan; Campbell Rogers; Daniel Berman; Manesh R Patel; Pamela S Douglas; Jonathon Leipsic
Journal:  JACC Cardiovasc Imaging       Date:  2020-08-26

4.  Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.

Authors:  Eri Minamino-Muta; Takao Kato; Takeshi Morimoto; Tomohiko Taniguchi; Moriaki Inoko; Tetsuya Haruna; Toshiaki Izumi; Shoichi Miyamoto; Eisaku Nakane; Kenichi Sasaki; Moritoshi Funasako; Koji Ueyama; Shinichi Shirai; Takeshi Kitai; Chisato Izumi; Kazuya Nagao; Tsukasa Inada; Eiji Tada; Akihiro Komasa; Katsuhisa Ishii; Naritatsu Saito; Ryuzo Sakata; Kenji Minatoya; Takeshi Kimura
Journal:  Heart       Date:  2017-07-06       Impact factor: 5.994

Review 5.  Coronary Microcirculation in Aortic Stenosis: Pathophysiology, Invasive Assessment, and Future Directions.

Authors:  Jo M Zelis; Pim A L Tonino; Nico H J Pijls; Bernard De Bruyne; Richard L Kirkeeide; K Lance Gould; Nils P Johnson
Journal:  J Interv Cardiol       Date:  2020-07-22       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.